Результаты поиска

Ирисин предотвращает повреждение трабекулярных костей и проникновение опухоли в мышиную модель множественной миэломы.

Болезни костей, связанные с множественной миеломой (ММ), характеризуются остеолитическими повреждениями и патологическими переломами, которые по-прежнему являются приоритетной терапевтической задачей, несмотря на новые лекарственные средства, способствующие выживанию пациентов с MM. Антирезорптивные молекулы представляют собой главный вариант лечения костного заболевания, связанного с MM (MMBD), в то время как остеоанаболические молекулы в настоящее время изучаются. Среди последних мы здесь сосредоточили внимание на миокиновом ирисине, который способен увеличить массу костей в здоровых мышах,

Expression and Regulation Network of HDAC3 in Acute Myeloid Leukemia and the Implication for Targeted Therapy Based on Multidataset Data Mining.

BackgroundHistone deacetylase 3 (HDAC3) plays an important role in the development and progression of a variety of cancers, but its regulatory mechanism in acute myeloid leukemia (LAML) is not entirely understood.MethodsWe analyzed the expression of HDAC3 in normal and cancerous tissues using Oncomine, UALCAN, and GEO databases. Changes of the HDAC3 gene were analyzed by cBioPortal. The genes coexpressed with HDAC3 were analyzed by WebGestalt, and the predicted signaling pathways in KEGG were discussed.ResultsWe discovered that the expression of HDAC3 was elevated in some types of acute myeloi

Assessment and monitoring of patients receiving chemotherapy for multiple myeloma: strategies to improve outcomes.

Improved understanding as to the biology of multiple myeloma (MM) and the bone marrow microenvironment has led to the development of new drugs to treat MM. This explosion of new and highly effective drugs has led to dramatic advances in the management of MM and underscores the need for supportive care. Impressive and deep response rates to chemotherapy, monoclonal antibodies, and small molecule drugs provide hope of a cure or prolonged remission for the majority of individuals. For most patients, long-term, continuous therapy is often required to suppress the malignant plasma cell clone, thus

Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial.

BackgroundIn the CALGB (Alliance) 100104 study, lenalidomide versus placebo after autologous stem-cell transplantation (ASCT) was investigated for patients with newly diagnosed myeloma. That study showed improved time to progression and overall survival and an increase in second primary malignancies for lenalidomide at a median follow-up of 34 months. Here we report an updated intention-to-treat analysis of CALGB (Alliance) 100104 at a median follow-up of 91 months.MethodsPatients were eligible for this randomised, double-blind, placebo-controlled, phase 3 trial if they had symptomatic disease

Несекретарша с несколькими миеломами с плохими реакциями на химиотерапию на основе Даратумумаба.

Несекретарская миелома (NSMM) — вариант множественных миелом, определяемый без обнаруживаемого секреции белка М в сыворотке или моче электрофорезе. Из-за отсутствия обнаруживаемого " пика М " диагноз часто является сложным и опирается на исследования костного мозга. В связи с отсутствием исследований, конкретно посвященных НУМР, нынешние руководящие принципы лечения основаны на исследованиях по скрытию множественной миеломы. В данном случае мы описываем следующее: 77-year-old пациентка с типичным представлением NSMM, которая не отреагировала на химиотерапию на основе daratumumab.

Iron deficiency in children at the time of initial neuroblastoma diagnosis.

ImportanceThere is a high incidence of iron deficiency in children worldwide. Notably, however, while iron deficiency is the most common cause of anemia, little is known about the prevalence and different types of iron deficiency in neuroblastoma patients.ObjectiveThe aim of the present study was to investigate the prevalence of iron deficiency in patients newly diagnosed with neuroblastoma.MethodsA total of 195 newly diagnosed neuroblastoma patients from November 2015 to January 2018 were analyzed retrospectively. The survival analysis was estimated by the Kaplan-Meier method.ResultsOf the 19

Проблемы, трудности и запоздалый диагноз множественной миеломы.

Фон: Множественная миелома (ММ) представляет собой разнородную плазменную порчу клеток с неконкретными симптомами и разнородностью болезней на клиническом и биологическом уровнях. Этот неконкретный набор симптомов, включая боль в костях, анемию, почечную недостаточность, гиперкальцемию и нейропатию, может ввести в заблуждение диагноз как хронические или доброкачественные заболевания, что приводит к задержкам в диагностике. Своевременное выявление имеет важнейшее значение для предотвращения повреждения органов и снижения заболеваемости. Методы: В настоящем обзоре мы представляем обзор последней

Modern radiopharmaceuticals for lung cancer imaging with positron emission tomography/computed tomography scan: A systematic review.

IntroductionIn this study, we evaluated the use and the contribution of radiopharmaceuticals to the field of lung neoplasms imaging using positron emission tomography/computed tomography.MethodsWe conducted review of the current literature at PubMed/MEDLINE until February 2020. The search language was English.ResultsThe most widely used radiopharmaceuticals are the following:Experimental/pre-clinical approaches: (18)F-Misonidazole (18F-MISO) under clinical development, D(18)F-Fluoro-Methyl-Tyrosine (18F-FMT), 18F-FAMT (L-[3-18F] (18)F-Fluorothymidine (18F-FLT)), (18)F-Fluoro-Azomycin-Arabinosi

Glasgow Prognostic Score and Gustave Roussy Immune Score in Hodgkin Lymphoma: Survival Associations and Limited Incremental Prognostic Value Beyond the International Prognostic Score.

Background/Objectives: Although outcomes in Hodgkin lymphoma (HL) have improved substantially, patients with advanced-stage disease, comorbidities, or relapsed/refractory presentations can still fare poorly. Blood-based indices of systemic inflammation and nutrition are derived from routine tests, but their value beyond established prognostic models is uncertain. We examined the association of the baseline Gustave Roussy Immune Score (GRIm) and Glasgow Prognostic Score (GPS) with treatment response, progression-free survival (PFS), and overall survival (OS) in HL, focusing on their performance

Воздействие почечной гистологии и выбора лечения на выживание пациентов с множественной миеломой.

Участие почек в пациентах с множественной миеломой имеет множество различных результатов в гистологии почек. Одной из основных причин смертности является потребность в постоянном диализе. Для предотвращения необходимости диализа и сокращения смертности необходимо быстрое начало современной терапии миэломы. СПРАВОЧНАЯ ИНФОРМАЦИЯ: Острые последствия или последствия CKD 20%-40% пациентов с множественной миеломой (ММ). Несмотря на то, что был установлен негативный прогнозный эффект участия почек, конкретные последствия различных гистологических моделей остаются недостаточно понятными. Мы стремилис

Совпадение в полном тексте источника
… Preprocedural coagulation studies were mandatory to minimize bleeding risk, and international normalized ratio and platelet count were optimized before biopsy if necessary. BP was closely monitored on the day of biopsy and maintained below 150/90 mm Hg when necessary. …

Efficacy in Japanese adults with growth hormone deficiency receiving weekly somapacitan or daily growth hormone: results from phase 3 REAL 1 trial.

IntroductionSomapacitan is a long-acting growth hormone (GH) derivative approved for once-weekly treatment of adult GH deficiency (AGHD). This study aimed to evaluate the efficacy and safety of somapacitan and daily GH in Japanese individuals with AGHD.MethodsThis subgroup study included the 34-week main period of the multinational, randomized, parallel-group, phase 3 trial, REAL 1 (NCT02229851). Participants received once-weekly somapacitan or daily GH (Norditropin®), both administered subcutaneously. Investigators and trial sites were blinded. A total of 36 Japanese GH-naïve individuals with

A differential diagnostic model based on immunological evaluation and routine laboratory tests: distinguishing multiple myeloma from other disorders with aberrant immunoglobulin elevation.

ObjectiveDevelop a diagnostic model using common hematological and immunological indicators to assist in the early screening and differential diagnosis of Multiple Myeloma (MM) in clinical settings, reducing the risk of misdiagnosis.MethodsA retrospective analysis was conducted on 274 newly diagnosed and treated MM patients and 137 connective tissue disease patients treated at Zhejiang Provincial People's Hospital from January 2008 to August 2023. Laboratory indicators, including complete blood count, biochemistry, coagulation function, and immunoglobulin markers, were collected. The cohort wa

Oncologic emergency in patients with skeletal metastasis of unknown primary.

AimPatients with skeletal metastasis from prediagnosed primary malignancy sometimes have concurrent oncologic emergency (OE) during the first visit. This study aims to investigate the types of OEs and treatment outcome in such patients.MethodsWe have experienced 359 patients with skeletal metastasis from unknown primary malignancy. Among them, 130 patients required immediate admission for OE treatment (OE group), 229 patients had no OE and did not required immediate admission (non-OE group).ResultsThe recognized types of OE were spinal cord compression in 60 patients, cancer pain in 30, hyperc

Preoperative Vitamin D as Predictor of MRONJ: A Retrospective Multivariate Analysis.

Background: Medication-related osteonecrosis of the jaw (MRONJ) is a grave complication in patients with cancer treated with antiresorptive agents, particularly after invasive dental procedures. Identifying reliable clinical factors to assess MRONJ risk remains a clinical challenge. Methods: The retrospective observational study comprised 61 oncologic patients undergoing dental extractions during antiresorptive therapy. Preoperative serum levels of 25-hydroxyvitamin D and β-C-terminal telopeptide cross-link (β-CTx), along with relevant clinical variables, were measured. The analyses included c

The Advent of Molecular Targeted Therapies Against Cancer. Toward Multi-Targeting Drugs Through Materials Engineering: A Possible Future Scenario.

The authors, actively engaged in the development of mesoporous silica-based solutions, initially for modified drug release, later for the smart administration of conventional chemotherapeutic cytotoxic drugs, present the evolution of the concept of targeted therapy across different disciplines. They also discuss the diverse therapeutic needs and related challenges (adverse drug effects) that have unfolded over the last 30 years. Nanomedicine potentialities, mainly against cancers, that have emerged globally during the intense research activity of the last few decades, are critically discussed.

Деменция у людей с множественным склерозом: систематический обзор и мета-анализ.

ВВЕДЕНИЕ: Множественный склероз (МС) как аутоиммунное демиелионирующее расстройство ассоциируется с когнитивной дисфункцией. Деменция может быть результатом серьезной когнитивной дисфункции или других путей в MS, однако точные механизмы и распространенность неизвестны. ЦЕЛЬ: Цель настоящего обзора заключалась в определении общей распространенности и риска слабоумия у людей с НР (МСУ). DESIGN: Этот метаанализ был проведен в соответствии с руководящими принципами, установленными Предпочтительными элементами отчетности для систематического обзора и мета-анализа (PRISMA).МЕТОДЫ: Эмбаза, Пубмед, На

Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia.

BackgroundLimited data are available regarding the cost-effectiveness of preventative therapies for postmenopausal women with osteopenia. The objective of the present study was to evaluate the cost-effectiveness of raloxifene, alendronate and conservative care in this population.MethodsWe developed a microsimulation model to assess the incremental cost and effectiveness of raloxifene and alendronate relative to conservative care. We assumed a societal perspective and a lifetime time horizon. We examined clinical scenarios involving postmenopausal women from 55 to 75 years of age with bone mine

Nanoparticles for Targeted Drug Delivery to Cancer Stem Cells: A Review of Recent Advances.

Cancer stem cells (CSCs) are a subpopulation of cells that can initiate, self-renew, and sustain tumor growth. CSCs are responsible for tumor metastasis, recurrence, and drug resistance in cancer therapy. CSCs reside within a niche maintained by multiple unique factors in the microenvironment. These factors include hypoxia, excessive levels of angiogenesis, a change of mitochondrial activity from aerobic aspiration to aerobic glycolysis, an upregulated expression of CSC biomarkers and stem cell signaling, and an elevated synthesis of the cytochromes P450 family of enzymes responsible for drug

Множественный склероз педиатрии (POMS) и эпилепсия: исследование этиологической сложности - результаты из опыта одного центра.

В этой статье рассматривается сложная взаимосвязь между припадками, эпилепсией и множественным склерозом (МС) у педиатрических пациентов на основе подробных результатов исследования, проведенного в одном центре. Справочная информация: Хотя множественный склероз в первую очередь признается в качестве заболевания, порождаемого взрослыми, его распространенность у детей сопряжена с особыми проблемами, особенно связанными с расстройствами припадков. Методы: Мы провели обзор 120 Число пациентов педиатрии, прошедших оценку 7 годы; six (из них)5%) опытных изъятий (включая one случай острого эпилептиче

Bortezomib-based regimens improve the prognosis of newly diagnosed MM patients with chromosomal aberrations except for del(17q13): A retrospective study from a single center.

AbstractChromosomal aberrations are generally considered to have a remarkable impact on the outcome of multiple myeloma. Bortezomib helps to achieve complete responses and leads to longer life expectancy in many multiple myeloma patients. This study was designed to clarify whether bortezomib can improve the poor prognosis resulting from del(17q13), del(13q14), amp(1q21), t(4,14), t(14,16) in patients with multiple myeloma. A total of 255 MM patients treated with bortezomib-based regimens were included in this study. All chromosomal aberrations were detected by interphase fluorescence in situ h